Apogee Therapeutics Inc

APGE

Company Profile

  • Business description

    Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

  • Contact

    221 Crescent Street
    Building 17, Suite 102b
    WalthamMA02453
    USA

    T: +1 650 394-5230

    https://www.apogeetherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    261

Stocks News & Analysis

stocks

Undervalued tech share oversold on AI fears

Has the market overlooked this ASX tech share?
stocks

Margins have bottomed for ASX listed consumer goods company

Impact of tariffs have been priced in.
stocks

SpaceX rally continues, expanding sky-high valuations

SpaceX has risen 50% from its IPO price to become the second-most-expensive stock under Morningstar’s coverage.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,031.209.400.10%
CAC 408,400.1121.03-0.25%
DAX 4025,139.69153.870.62%
Dow JONES (US)51,712.71148.010.29%
FTSE 10010,437.8574.580.72%
HKSE23,768.52156.29-0.65%
NASDAQ26,166.60351.33-1.32%
Nikkei 22572,353.961,103.901.55%
NZX 50 Index13,446.0549.58-0.37%
S&P 5007,472.7927.79-0.37%
S&P/ASX 2008,816.1014.200.16%
SSE Composite Index4,163.1072.621.78%

Market Movers